Market Leader Strategies: AstraZeneca Defending its Turf

            
 
Strategic Management|Management Strategy |Business Strategy Case Study|Business Strategy|Case Study|Case Studies

ICMR HOME | Case Studies Collection

To download Market Leader Strategies: AstraZeneca Defending its Turf case study (Case Code: BSTR271) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here

Business Strategy Case Studies
Case Studies Collection
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Case Studies by Area
Case Studies by Industry
Case Studies by Company

Custom Search



Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

Case Details:

Price:

Case Code : BSTR271 For delivery in electronic format: Rs. 400;
For delivery through courier (within India): Rs. 400 + Rs. 25 for Shipping & Handling Charges

Themes

Growth Strategies | Product Lifecycle Management
Case Length : 19 pages
Period : 2001-2007
Pub Date : 2008
Teaching Note : Available
Organization : AstraZeneca Plc.
Industry : Pharma and Biotech
Countries : Europe; USA

Abstract:

This case is about one of the world's top pharmaceutical companies, AstraZeneca Plc.'s (AstraZeneca) strategic defense of its market leadership in the Gastrointestinal (GI) drugs market. The company had dominated the GI drugs market, more specifically the acid-related disorder market, ever since it launched the drug Omeprazole (a Proton Pump Inhibitor) which was marketed as Losec worldwide and Prilosec in the US. Losec/Prilosec became one of the world's top best selling drugs in the 1990s. As the drug was scheduled to lose its patent protection in 2001, the company put together a cross-functional team in 1995 to formulate a strategy that would ensure that the company did not lose its market share due to the patent expiry.

Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

This resulted in the company coming out with a new drug (Esomeprazole) that was but a mirror image of Omeprazole. AstraZeneca branded the new drug as Nexium and started efforts to switch the existing sales of Losec/Prilosec to Nexium.

The strategy proved to be very successful as AstraZeneca was able to maintain the leadership position in the GI drugs market even after the patent expiry of its blockbuster drug. As of 2006, Nexium was ranked second among world's largest selling drugs, and its marketing had won AstraZeneca and its ad agencies a number of awards and recognition in marketing. However, AstraZeneca's strategy also came in for strong criticism with many critics contending that the success of Nexium was a triumph of marketing over science. The company also faced several lawsuits regarding its strategy for Nexium.

Issues:

Understand the issues and challenges faced by market leaders in a particular segment in maintaining its leadership position.

Understand the issues and challenges faced by companies in managing the product lifecycle (PLC) of the drug with special emphasis on the defence strategy against multiple cost-based competitors.

Understand the marketing and branding initiatives adopted by AstraZeneca for Nexium.

Understand the ethical issues related to marketing and promotion of a drug.

Contents:

  Page No.
Averting The Shark Fin 1
Background Note 2
Losec/Prilosec - The Purple Pill 3
The Impending Shark Fin 4
The Shark Fin Project 5
Launching Nexium 7
Strategy for Losec/Prilosec 8
Results 9
Triumph of Marketing 11
Critics at Large 12
Outlook 13
Exhibits 15

Keywords:

Market leader strategies, Sandwich strategy, Intellectual property management, Defense strategy, Product Lifecycle management strategy, Shark fin curve, e-detailing, Branding , Ethics, AstraZeneca, Marketing, Prilosec, Nexium, Procter & Gamble, Pharmaceutical , Marketing

Averting The Shark Fin - Next Page >>


Custom Search



 

Case Studies in Business Strategy Volume VI

Case Studies in Business Strategy
e-Book on Business Strategy

Case Study Volumes Collection

 


Cases on Related Topics :- Wal-Mart's German Misadventure, Wal-Mart Struggles in Japan, Coca-Cola's Business Practices: Facing the Heat in a Few Countries

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.